Cell Expansion Market estimated worth 18.76 Billion USD by 2021

1
MarketsandMarkets Presents
Cell Expansion Market North American and
Europe to Offer Growth Opportunities
http//www.marketsandmarkets.com/Market-Reports/ce
ll-expansion-market-194978883.html
2
The report "Cell Expansion Market by Product
(Reagent, Media, Flow Cytometer, Centrifuge,
Bioreactor), Cell Type (human, animal),
Application (Regenerative Medicine Stem Cell
Research, Cancer), End user (Research Institute,
Cell Bank) - Global Forecasts to 2021", report
provides a detailed overview of the major
drivers, restraints, challenges, opportunities,
current market trends, and strategies impacting
the cell expansion market along with the
estimates and forecasts of the revenue and market
share analysis. Browse 168 market data
tables 48 figures 189 pages and in-depth TOC on
"Cell Expansion Market Download The PDF
Brochure_at_ http//www.marketsandmarkets.com/pdfdown
load.asp?id194978883 The global cell expansion
market is expected to reach USD 18.76 Billion by
2021 from USD 8.34 Billion in 2016 at a CAGR of
17.6 from 2016 to 2021. 
www.marketsandmarkets.com/Market-Reports/cell-expa
nsion-market-194978883.html
3
The major factors driving the growth of this
market are increasing government funding for
research, high prevalence of chronic diseases,
rising company investments for the development of
cell-based products, and growing number of
GMP-certified production facilities. Speak to
Analyst_at_ http//www.marketsandmarkets.com/speaktoa
nalyst.asp?id194978883 The report segments this
market based on product, cell type, application,
end user, and region. Among products, the
consumables segment is expected to account for
the largest share of the market. The consumables
market includes reagents, media and sera, and
disposables. Disposables are further classified
into tissue culture flasks, bioreactor
accessories, and other disposables. The reagents,
media, and sera segment is projected to grow at
the highest CAGR from 2016 to 2021 due to
increasing investments for cell-based
research. .  
www.marketsandmarkets.com/Market-Reports/cell-expa
nsion-market-194978883.html
4
On the basis of cell type, the cell expansion
market is segmented into human cells and animal
cells. The human cells segment is expected to
account for the largest share of the global cell
expansion market in 2016. This segment is
expected to grow at the highest rate due to
increasing research investments by public and
private organizations. Human cells include stem
cells and differentiated cells. The stem cells
segment is classified into adult stem cells,
embryonic stem cells, and induced pluripotent
stem cells. The applications segments included
in the cell expansion market are regenerative
medicine and stem cell research, cancer and
cell-based research, and others. The regenerative
medicine and stem cell research segment is
expected to account for the largest share of the
global cell expansion market in 2016. Increasing
investments by companies for the development of
cell-based therapies are driving the growth of
this market.
www.marketsandmarkets.com/Market-Reports/cell-expa
nsion-market-194978883.html
5
End users included in the cell expansion market
are research institutes, biopharmaceutical and
biotechnology companies, cell banks, and others.
The research institutes segment is expected to
account for the largest share of the global cell
expansion market in 2016. The increasing
prevalence of diseases and rising government
investments for RD will drive the growth of this
market. Based on region, the global cell
expansion market is segmented into North America,
Europe, Asia, and the Rest of the World (RoW).
North America is expected to account for the
largest share of the market during the forecast
period. Growth in this segment is driven by
increasing government funding for cell-based
research. Key players in the cell expansion
market include Beckman Coulter, Inc. (U.S.),
Becton, Dickinson and Company (U.S.), Corning,
Inc. (U.S.), GE Healthcare (U.K.), Lonza
(Switzerland), Merck KGaA (Germany), Miltenyi
Biotec (Germany), STEMCELL Technologies, Inc.
(Canada), Terumo BCT, Inc. (U.S.), and Thermo
Fisher Scientific, Inc. (U.S.).
www.marketsandmarkets.com/Market-Reports/cell-expa
nsion-market-194978883.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.  MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/ce
ll-expansion-market-194978883.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets
8
(No Transcript)